Search Results 2201-2210 of 13074 for transexamic

1. A Study of Vutrisiran (ALN-TTRSC02) in Patients with Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis) - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness and safety of vutrisiran (ALN-TTRSC02) in patients with hereditary transthyretin amyloidosis (hATTR ...

2. BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care versus Standard of Care Alone in the Treatment of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome in Patients post Single Lung Transplantation - Mayo Clinic

   BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal ...

3. Publications - Carla P. Venegas, M.D. - Mayo Clinic

   Shuman M, Rola P, Venegas C. The Crossroad: Fluid Responsiveness, Fluid Overload or Fluid Tolerance in the Critically Ill. Crit Care Clin.

4. Mayo Clinic Cancer Center researchers identify promising drug to treat gastrointestinal cancers

   PHOENIX ― Gastrointestinal cancers are some of the most commonly diagnosed cancers, and they continue to be associated with poor survival outcomes.

5. First aid for a choking person - Mayo Clinic

   If a person is choking and cannot talk, cry or laugh forcefully, the American Red Cross recommends this approach to delivering first aid.

6. Resilience training - Doctors & Departments - Mayo Clinic

   Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

7. Nonalcoholic Steatohepatitis Clinical Trials - Mayo Clinic Research

   The purpose of this study is to investigate the effectiveness and safety of three dose levels of subcutaneous semaglutide for the treatment of patients who have ...

8. News - Clifford R. Jack, Jr., M.D. - Mayo Clinic

   Double your impact on cancer! ... Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge. Give Now.

9. Complementary Medicine Provides Healing Touch for Patient in Final Days - Mayo Clinic News Network

   Marilyn and David Weissing, both Mayo Clinic employees, knew something was wrong when their 19-year-old son, Karl, asked to be taken to the hospital one ...

10. Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients - Mayo Clinic

    The purpose of this study is to provide nephrologists with additional clinical evidence regarding the efficacy and safety of Acthar in subjects with treatment- ...